These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10768643)

  • 1. Effectiveness of infliximab in the treatment of refractory perineal cutaneous Crohn disease.
    Geyer AS; Anhalt GJ; Nousari HC
    Arch Dermatol; 2000 Apr; 136(4):459-60. PubMed ID: 10768643
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous metastatic Crohn's disease responsive to infliximab.
    Petrolati A; Altavilla N; Cipolla R; Fenderico P; Forlini G; Nasoni S; Rossi Z
    Am J Gastroenterol; 2009 Apr; 104(4):1058. PubMed ID: 19259072
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.
    Tan MH; Gordon M; Lebwohl O; George J; Lebwohl MG
    Arch Dermatol; 2001 Jul; 137(7):930-3. PubMed ID: 11453813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease.
    Batres LA; Mamula P; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2002 May; 34(5):558-60. PubMed ID: 12050585
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn's disease.
    Teich N
    Tech Coloproctol; 2014 Oct; 18(10):965-6. PubMed ID: 24965074
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Crohn's disease of the face.
    Graham DB; Jager DL; Borum ML
    Dig Dis Sci; 2006 Nov; 51(11):2062-3. PubMed ID: 17009111
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful use of adalimumab in treating cutaneous metastatic Crohn's disease: report of a case.
    Miller FA; Jones CR; Clarke LE; Lin Z; Adams DR; Koltun WA
    Inflamm Bowel Dis; 2009 Nov; 15(11):1611-2. PubMed ID: 19090557
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease.
    Gill KR; Mahadevan U
    Inflamm Bowel Dis; 2005 Feb; 11(2):210-2. PubMed ID: 15677920
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic Crohn's disease: a review and approach to therapy.
    Kurtzman DJ; Jones T; Lian F; Peng LS
    J Am Acad Dermatol; 2014 Oct; 71(4):804-13. PubMed ID: 24888520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for the treatment of hidradenitis suppurativa.
    Lebwohl B; Sapadin AN
    J Am Acad Dermatol; 2003 Nov; 49(5 Suppl):S275-6. PubMed ID: 14576652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual case of Crohn's disease in a West Indian child.
    Wallis SM; Walker-Smith J
    Acta Paediatr Scand; 1976 Nov; 65(6):749-51. PubMed ID: 998232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous ulceration in Crohn's disease.
    Mountain JC
    Gut; 1970 Jan; 11(1):18-26. PubMed ID: 5435264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases.
    Cocco A; Angelucci E; Viscido A; Caprilli R
    Inflamm Bowel Dis; 2007 Oct; 13(10):1317-9. PubMed ID: 17508417
    [No Abstract]   [Full Text] [Related]  

  • 15. Intralesional infliximab in noninfectious cutaneous granulomas: three cases of necrobiosis lipoidica.
    Barde C; Laffitte E; Campanelli A; Saurat JH; Thielen AM
    Dermatology; 2011; 222(3):212-6. PubMed ID: 21625077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab treatment failure in a case of cutaneous Crohn's disease.
    Yang DJ; Hsu S
    J Am Acad Dermatol; 2005 Nov; 53(5):903-4. PubMed ID: 16243156
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
    Rosen T; Doherty C
    Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab in the treatment of a child with cutaneous granulomas associated with ataxia telangiectasia.
    Mitra A; Gooi J; Darling J; Newton-Bishop JA
    J Am Acad Dermatol; 2011 Sep; 65(3):676-677. PubMed ID: 21839336
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyoderma gangrenosum associated with inflammatory bowel disease. Report of two cases with good response to infliximab.
    Carrasco Cubero C; Ruiz Tudela MM; Salaberri Maestrojuan JJ; Pérez Venegas JJ
    Reumatol Clin; 2012; 8(2):90-2. PubMed ID: 22104047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.
    Devos SA; Van Den Bossche N; De Vos M; Naeyaert JM
    Dermatology; 2003; 206(4):388-90. PubMed ID: 12771494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.